The Glenmede’s Small Cap Strategy outperformed the Russell 2000 in Q2 and year to date, the fifth consecutive quarter of outperformance. Portfolio Manager Christopher Colarik discusses the strong stock selection in the quarter, particularly in Health Care and Industrials. Negative relative contributions came from Communication Services. Stock selection in Health Care benefited from not owning biotech, which was down for the quarter.